Allogeneic Hematopoietic Cell Transplantation (HCT) May Abrogate the Poor Prognosis for Patients with KMT2A Rearranged (KMT2Ar) B-Lineage Acute Lymphoblastic Leukemia (ALL)

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Tamer Adel Othman, Zaid Abdel Rahman, Rima M. Saliba, Paul Koller, Ibrahim Taha Aldoss, Partow Kebriaei

DOI: 10.1016/j.jtct.2025.12.167

Cited by: 0

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation CAR-T cell therapy research